Nexinadi Tablets
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
MFDS item code 201508510 · Approved 2015.12.30
This product's status changed to Approval withdrawn on 2024.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers and gastritis); prevention of Mendelson syndrome
This medication is used for gastrointestinal diseases such as gastric ulcers, gastritis, and duodenal ulcers. It is also helpful in the treatment of Zollinger-Ellison syndrome and gastroesophageal reflux disease. It is administered to prevent ulcers that may occur post-surgery and to prevent Mendelson syndrome before anesthesia. This medication is particularly effective for treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to alleviate and treat the symptoms of various gastrointestinal diseases.
Usually, take 1 tablet twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers: Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for the prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and other ulcers usually heal within 8 weeks, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 1 tablet once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. For severe disease, up to 6g per day as ranitidine may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, and acute gastric mucosal lesions: When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery. For patients with severe renal impairment and creatinine clearance of 50ml/min or less, take 1 tablet once daily at bedtime. This may vary depending on the patient's condition. Since hemodialysis reduces the blood concentration of the medication, readjust the dosing schedule immediately after hemodialysis.
Children 8-18 years of age: 1 tablet per dose (equivalent to ranitidine 2mg/kg) may be taken up to twice daily.
This medication should not be used by patients undergoing dialysis treatment. Patients with a history of allergic reactions to ranitidine hydrochloride should not take this medication. Patients with impaired kidney function may have increased blood drug concentration, so the dosage should be reduced or the dosing interval extended for careful use. Patients with impaired liver function should also use this medication with caution. Patients with a history of drug allergies or elderly patients should be careful when using this medication. During the course of this medication, severe allergic reactions or shock symptoms may rarely occur, so if symptoms develop, discontinue the medication immediately and notify a healthcare professional. Symptoms such as skin rash, angioedema, fever, bronchospasm, and hypotension may also occur rarely, so caution is advised. Blood tests may show a decrease in white blood cells or platelets, and liver function test values may temporarily increase. Cardiovascular abnormalities such as heart rhythm disturbances or arrhythmias have also been reported rarely. Gastrointestinal symptoms such as nausea, vomiting, constipation, diarrhea, abdominal swelling, and abdominal pain may occur. Stool color may change or turn black, but this is due to the properties of the medication and does not require treatment. Neuropsychiatric symptoms such as dizziness, drowsiness, confusion, seizures, depression, hallucinations, insomnia, and headache may occur rarely. Gynecomastia and sexual dysfunction have been reported, but a direct causal relationship to this medication is not clear. Joint pain, skin rash, hair loss, itching, and tongue discoloration may also occur rarely. It is recommended not to use this medication for prolonged periods, and if there is a history of kidney disease, consultation with a doctor or pharmacist is essential before use. The treatment effect should be monitored carefully, and if there is no effect, another medication may be considered. Women who are pregnant or may become pregnant should only use this medication if the benefit clearly outweighs the risk, as safety has not been established. If breastfeeding, discontinuation of the medication is advised as it may be transmitted through breast milk. Safety in children has not been sufficiently confirmed, so caution is required when used in this population. Some urine tests may show false-positive reactions while taking this medication, so it is recommended to use specific testing methods for accurate tests. In case of overdose, measures such as vomiting or gastric lavage are necessary, and in severe cases, blood dialysis may be needed to remove the medication. This medication may conceal symptoms of gastric cancer, so it should be used only after confirming the malignancy.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to keep the medication effective longer.
Green rectangular film-coated tablets
30 tablets, 300 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.